Literature DB >> 33631743

Acute Response of Human Aortic Endothelial Cells to Loss of Pulsatility as Seen during Cardiopulmonary Bypass.

Khanh T Nguyen1,2,3, Leslie Donoghue1,2,3, Guruprasad A Giridharan4, Jeffrey P Naber5, Doug Vincent5, Kiyotaka Fukamachi6, Arushi Kotru1,2,3, Palaniappan Sethu7,8,9.   

Abstract

Cardiopulmonary bypass (CPB) results in short-term (3-5 h) exposure to flow with diminished pulsatility often referred to as "continuous flow". It is unclear if short-term exposure to continuous flow influences endothelial function, particularly, changes in levels of pro-inflammatory and pro-angiogenic cytokines. In this study, we used the endothelial cell culture model (ECCM) to evaluate if short-term (≤5 h) reduction in pulsatility alters levels of pro-inflammatory/pro-angiogenic cytokine levels. Human aortic endothelial cells (HAECs) cultured within the ECCM provide a simple model to evaluate endothelial cell function in the absence of confounding factors. HAECs were maintained under normal pulsatile flow for 24 h and then subjected to continuous flow (diminished pulsatile pressure and flow) as observed during CPB for 5 h. The ECCM replicated pulsatility and flow morphologies associated with normal hemodynamic status and CPB as seen with clinically used roller pumps. Levels of angiopoietin-2 (ANG-2), vascular endothelial growth factor-A (VEGF-A), and hepatocyte growth factor were lower in the continuous flow group in comparison to the pulsatile flow group whereas the levels of endothelin-1 (ET-1), granulocyte colony stimulating factor, interleukin-8 (IL-8) and placental growth factor were higher in the continuous flow group in comparison to the pulsatile flow group. Immunolabelling of HAECs subjected to continuous flow showed a decrease in expression of ANG-2 and VEGF-A surface receptors, tyrosine protein kinase-2 and Fms-related receptor tyrosine kinase-1, respectively. Given that the 5 h exposure to continuous flow is insufficient for transcriptional regulation, it is likely that pro-inflammatory/pro-angiogenic signaling observed was due to signaling molecules stored in Weible-Palade bodies (ET-1, IL-8, ANG-2) and via HAEC binding/uptake of soluble factors in media. These results suggest that even short-term exposure to continuous flow can potentially activate pro-inflammatory/pro-angiogenic signaling in cultured HAECs and pulsatile flow may be a successful strategy in reducing the undesirable sequalae following continuous flow CPB.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Continuous flow; Diminished pulsatility; Endothelial dysfunction

Mesh:

Substances:

Year:  2021        PMID: 33631743     DOI: 10.1159/000512558

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.208


  4 in total

Review 1.  Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support.

Authors:  Carl P Walther; Andrew B Civitello; Kenneth K Liao; Sankar D Navaneethan
Journal:  Kidney360       Date:  2022-01-14

Review 2.  Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing.

Authors:  Leslie Donoghue; Khanh T Nguyen; Caleb Graham; Palaniappan Sethu
Journal:  Micromachines (Basel)       Date:  2021-01-28       Impact factor: 2.891

3.  Circulating miRNAs and Vascular Injury Markers Associate with Cardiovascular Function in Older Patients Reaching End-Stage Kidney Disease.

Authors:  Qiao Zhao; Sabine J L Nooren; Laurien E Zijlstra; Jos J M Westenberg; Lucia J M Kroft; J Wouter Jukema; Noeleen C Berkhout-Byrne; Ton J Rabelink; Anton Jan van Zonneveld; Marjolijn van Buren; Simon P Mooijaart; Roel Bijkerk
Journal:  Noncoding RNA       Date:  2022-01-10

4.  Bicuspidalization of the Native Tricuspid Aortic Valve: A Porcine in Vivo Model of Bicuspid Aortopathy.

Authors:  Naoyuki Kimura; Ryo Itagaki; Masanori Nakamura; Alimuddin Tofrizal; Megumi Yatabe; Takamichi Yoshizaki; Ryo Kokubo; Shuji Hishikawa; Satoshi Kunita; Hideo Adachi; Yoshio Misawa; Takashi Yashiro; Koji Kawahito
Journal:  Ann Vasc Dis       Date:  2022-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.